title: Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors.
abstract: OBJECTIVE
  Hypopituitarism frequently follows pituitary neurosurgery (NS) and/or irradiation. However, the frequency of hypothalamic-pituitary dysfunction after NS of non-pituitary intracranial tumors is unclear. The aim of this study was to assess the presence of endocrine alterations in patients operated on for intracranial tumors.
  
  
  METHODS
  This is a retrospective study.
  
  
  METHODS
  We studied 68 consecutive adult patients (28 female, 40 male, age 45.0 +/- 1.8 years; body mass index (BMI): 26.5 +/- 0.6) with intracranial tumors who underwent NS only (n = 17) or in combination with radiotherapy (RT) and/or chemotherapy (CT) (n = 51). In all subjects, basal endocrine parameters and the GH response to GHRH + arginine test (using BMI-dependent cut offs) were evaluated.
  
  
  RESULTS
  In 20.6% of the patients, peripheral endocrinopathy related to CT and/or RT was present. Hypopituitarism was found in 38.2% of the patients. Total pituitary hormone, multiple pituitary hormone, and isolated pituitary hormone deficits were present in 16.2, 5.8, and 16.2% respectively. The most common pituitary deficits were, in decreasing order: LH/FSH 29.4%, GH 27.9%, ACTH 19.1%, TSH 17.7%, and diabetes insipidus 4.4%. Hyperprolactinemia was present in 13.2%. The prevalence of hypopituitarism was higher in patients who underwent NS only and with tumors located closely to the sella turcica, but a substantial proportion of patients with tumors not directly neighboring the sella also showed hypopituitarism.
  
  
  CONCLUSIONS
  Hypopituitarism frequently occurs after NS for intracranial tumors. Also, exposure of these patients to CT and/or RT is frequently associated with peripheral endocrinopathies. Thus, endocrine evaluation and follow-up of patients treated for intracranial tumors should be performed on a regular basis.
authors.affiliation: Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Italy.
authors.forename: H J
authors.initials: HJ
authors.lastname: Schneider
authors.forename: S
authors.initials: S
authors.lastname: Rovere
authors.forename: G
authors.initials: G
authors.lastname: Corneli
authors.forename: C G
authors.initials: CG
authors.lastname: Croce
authors.forename: V
authors.initials: V
authors.lastname: Gasco
authors.forename: R
authors.initials: R
authors.lastname: Rudà
authors.forename: S
authors.initials: S
authors.lastname: Grottoli
authors.forename: G K
authors.initials: GK
authors.lastname: Stalla
authors.forename: R
authors.initials: R
authors.lastname: Soffietti
authors.forename: E
authors.initials: E
authors.lastname: Ghigo
authors.forename: G
authors.initials: G
authors.lastname: Aimaretti
mesh_terms: D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000150:complications* / Q000453:epidemiology / Q000601:surgery*; D004700:Endocrine System Diseases / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D007018:Hypopituitarism / Q000453:epidemiology / Q000209:etiology; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010907:Pituitary Hormones / Q000172:deficiency; D012189:Retrospective Studies
chemical_list: D010907:Pituitary Hormones